Table 1 Antimicrobial susceptibility pattern among MDR and non-MDR K. pneumoniae isolates
Antimicrobial agents | No. (%) in MDR-isolates | No. (%) in Non-MDR isolates | ||||
|---|---|---|---|---|---|---|
S | I | R | S | I | R | |
LEV | 36 (36%) | 3 (3%) | 19 (19%) | 38 (38%) | 0 (0%) | 4 (4%) |
CAZ | 10 (10%) | 7 (7%) | 41 (41%) | 32 (32%) | 2 (2%) | 8 (8%) |
CTX | 11 (11%) | 8 (8%) | 39 (39%) | 29 (29%) | 4 (4%) | 9 (9%) |
FEP | 15 (15%) | 5 (5%) | 38 (38%) | 36 (36%) | 3 (3%) | 3 (3%) |
ETP | 35 (35%) | 3 (3%) | 20 (20%) | 38 (38%) | 1 (1%) | 3 (3%) |
AK | 45 (45%) | 5 (5%) | 8 (8%) | 41 (41%) | 1 (1%) | 0 (0%) |
MER | 17 (17%) | 2 (2%) | 39 (39%) | 39 (39%) | 0 (0%) | 3 (3%) |
CRO | 14 (14%) | 6 (6%) | 38 (38%) | 35 (35%) | 3 (3%) | 4 (4%) |
SAM | 1 (1%) | 1 (1%) | 56 (56%) | 0 (0%) | 5 (5%) | 37 (37%) |
CFP | 11 (11%) | 4 (4%) | 43 (43%) | 32 (32%) | 1 (1%) | 9 (9%) |
IPM | 26 (26%) | 2 (2%) | 30 (30%) | 39 (39%) | 0 (0%) | 3 (3%) |
NIT | 2 (2%) | 3 (3%) | 53 (53%) | 25 (25%) | 13 (13%) | 4 (4%) |
GM | 40 (40%) | 1 (1%) | 17 (17%) | 35 (35%) | 1 (1%) | 6 (6%) |
CIP | 31 (31%) | 0 (0%) | 27 (27%) | 65 (65%) | 0 (0%) | 7 (7%) |
TET | 22 (22%) | 17 (17%) | 19 (19%) | 33 (33%) | 6 (6%) | 3 (3%) |
SXT | 13 (13%) | 4 (4%) | 41 (41%) | 31 (31%) | 2 (2%) | 9 (9%) |